Skip to content

Scholar Rock SRRK Unrealized gains (losses) on available-for-sale securities

Unrealized gains (losses) on available-for-sale securities at other companies

Edgewise Therapeutics, Inc. logo
Edgewise Therapeutics, Inc.EWTX
-$929K-4,789%
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
-$344K-122%
Cytokinetics logo
CytokineticsCYTK
-$1.84M-240%
Erasca, Inc. logo
Erasca, Inc.ERAS
-$1.33M-695%
Rhythm Pharmaceuticals, Inc. logo
Rhythm Pharmaceuticals, Inc.RYTM
-$544K-5,340%
Biogen logo
BiogenBIIB

Other financials

Income statement

See full
Revenue-
Operating income-$102.0M-32.3%
Net income-$105.5M-41.2%
EPS (diluted)-$0.83-23.9%

Balance sheet

See full
Cash & equivalents$430.5M+212%
Total debt$205.7M+226%
Total equity$276.0M-11.6%
Total assets$535.3M+31.3%

Cash flow

See full
Operating cash flow-$82.1M-4.4%
CapEx$68.0K-74.9%
Free cash flow-$82.2M-4.1%

Valuation

See full
Market cap$6.14B+85.5%

Profitability

See full
Operating margin-231.8%
Net margin-236.9%
FCF margin-309.1%

Returns & leverage

See full
Return on equity-138.9%+60.1pp
Debt / equity0.7×+0.5×
Current ratio8.6×-1.6×

Where this comes from

Reported directly by Scholar Rock in its filing.

Tagged under the XBRL concept us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax.

The official record: Scholar Rock’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Scholar Rock's unrealized gains (losses) on available-for-sale securities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Scholar Rock's unrealized gains (losses) on available-for-sale securities?
Scholar Rock (SRRK) reported unrealized gains (losses) on available-for-sale securities of -$71K in Q1 2026.
How has Scholar Rock's unrealized gains (losses) on available-for-sale securities changed year-over-year?
Scholar Rock's unrealized gains (losses) on available-for-sale securities decreased by 129.0% year-over-year, from -$31K to -$71K.
What is the long-term trend for Scholar Rock's unrealized gains (losses) on available-for-sale securities?
Over 4 years (2021 to 2025), Scholar Rock's unrealized gains (losses) on available-for-sale securities has grown at a 18.0% compound annual growth rate (CAGR), from -$33K to -$64K.
What does unrealized gains (losses) on available-for-sale securities mean?
This represents the change in the fair market value of investment securities classified as available-for-sale that has not yet been realized through a sale. It captures unrealized gains or losses resulting from market fluctuations in the company's investment portfolio. Monitoring this helps investors understand the volatility and potential liquidity impact of the company's non-operating asset holdings.